May 24, 2013
Daiichi Sankyo claimed on May 22 that the company believes former shareholders of its subsidiary Ranbaxy Laboratories, of India, which recently pleaded guilty to Good Manufacturing Practice (GMP) violations and data falsification, hid information about the US Department of Justice...read more